On October 22, 2020, the 83rd China International Medical Equipment Fair (CMEF) with the theme of "Innovative Technology Leading the Future" came to a close at the National Convention and Exhibition Center (Shanghai).

This CMEF exhibition includes the public health prevention and control exhibition area, the medical imaging exhibition area, the IVD in-vitro diagnostic exhibition area, the medical optics exhibition area, the disinfection and sensory control exhibition area, etc., which presents the medical health industry chain in a three-dimensional manner, focusing on various segments of the industry develop new trends, and explore a new future for industrial development. In the IVD in-vitro diagnostic exhibition area, technology products in the fields of biochemical immunity, molecular diagnostics, microbiology, blood, chemiluminescence are gathered, and the J11 booth of Minkang Biotechnology is being set up here.

Minkang Biotechnology brings star products such as MK-SY 01+, MK-SY 102, MK-ZY 801, at the same time, there are two blood glucose meters MK-SY 01Pro and MK-SY 020, and MK-KT 010 blood glucose and blood ketone meter. The MK-LP 711 blood lipid and blood glucose meter, four new products that are about to be launched, were unveiled together.

In addition to actively promoting blood glucose meter products and promoting the core technology system, Minkang is also actively promoting diabetes-related knowledge, advocating patients to exercise, reasonable diet and drugs to control blood sugar, and relying on data analysis and research to provide disease management information scientific program. A special interactive game zone for spinning bikes was set up at the booth site to increase public awareness of reducing blood sugar during exercise, and a fun Q&A session to popularize diabetes knowledge. In addition, the chronic disease management cloud platform built by Minkang Biotechnology was further demonstrated in this exhibition. With the continuous development of Internet medical care, the integrated model of online and offline diagnosis and treatment is bound to attract more attention. Ecosystem construction has become a key direction for manufacturers in the future.

In the future, Minkang Biotechnology will continue to adhere to the core values of "technology is the foundation of enterprise development, innovation is the core power of enterprise development, and benefit sharing is the principle of enterprise development", relying on the advanced technology of product , excellent quality, and a win-win strategic cooperation with integrity policy, strive to serve the market and the majority of diabetic patients.